Business Wire

Fresenius Kabi Introduces Generic Iodixanol Contrast Media Agent

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it will introduce a portfolio of generic contrast media agents in the United States, starting immediately with the launch of ...
Business Wire

Fresenius Kabi Expands Contrast Agent Portfolio with Launch of Gadoterate Meglumine Injection, USP

LAKE ZURICH, Ill.--(BUSINESS WIRE)--Fresenius Kabi announced today it has launched Gadoterate Meglumine Injection, USP, a bioequivalent and therapeutic equivalent substitute for the contrast agent ...
Morningstar

Bracco Receives Health Canada Approval for VUEWAY® injection (gadopiclenol), Advancing Lower-Dose MRI Contrast Imaging

Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
Medscape

Inappropriate Use of Pharmacy Bulk Packages of IV Contrast Media Increases Risk of Infections

Problem: Recently, the Centers for Disease Control and Prevention (CDC) reiterated its position calling for medications labeled as "single dose" or "single use" to be ...
Healio

Patients with iodinated contrast media allergy have five-fold increased mortality risk

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. 53% of patients with an iodinated contrast allergy and ...
EurekAlert!

Effect of warming CT contrast media on extravasations and patient reaction rates

AJR: resources required to warm iohexol 350 to body temperature before injection for CT may not be warranted, given lack of observed practical benefit “The data suggest that maintaining iohexol 350 at ...